Synapse - Susan Prockop

Search Within

Susan E Prockop

Results (262)

Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation

Journal Article

Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
Blood (2014)

Fulltext@MSK | Save

Allogeneic human mesenchymal stem cell therapy (Remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients

Journal Article

Kurtzberg, J.; Prockop, S.; Teira, P.; Bittencourt, H.; Lewis, V.; Chan, K. W.; Horn, B.; Yu, L.; Talano, J. A.; Nemecek, E.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplantation of patients with Wiskott-Aldrich syndrome with total body irradiation (TBI), thiotepa and fludarabine or cyclophosphamide followed By T-cell depleted grafts from alternative donors

Meeting Abstract

Prockop, S. E.; Boulad, F.; Kernan, N. A.; Khalif, R.; Kobos, R.; Scaradavou, A.; O'Reilly, R. J.
Blood (2013)

Fulltext@MSK | Save

Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)

Meeting Abstract

Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
Blood (2013)

Fulltext@MSK | Save

High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation

Meeting Abstract

Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
Blood (2013)

Fulltext@MSK | Save

Adoptive treatment of EBV-associated leiomyosarcoma in immunodeficient patients with EBV specific cytotoxic T cells

Meeting Abstract

Prockop, S. E.; Doubrovina, E.; Boulad, F.; Kernan, N. A.; Kobos, R.; Scaradavou, A.; Abramson, S. J.; Laquaglia, M.; Price, A.; O'Reilly, R. J.
Blood (2013)

Fulltext@MSK | Save

Adoptive transfer of WT-1 specific HLA class 2 restricted donor-derived T-cells induces sustained remission of AML relapse post transplant presenting as leukemia cutis

Meeting Abstract

Prockop, S. E.; Doubrovina, E.; Adams, R.; Boulad, F.; Kernan, N. A.; O'Reilly, R. J.
Blood (2013)

Fulltext@MSK | Save

Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)

Meeting Abstract

Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
Blood (2013)

Fulltext@MSK | Save

Generation and characterization of a third party GMP grade bank of CMV specific T-cells for adoptive immunotherapy of CMV infections in recipients of HSCT from cord blood or seronegative donors

Meeting Abstract

Hasan, A. N.; Doubrovina, E.; Koehne, G.; Prockop, S. E.; O'Reilly, R. J.
Blood (2013)

Fulltext@MSK | Save

First US phase I clinical trial of globin gene transfer for the treatment of beta-thalassemia major

Meeting Abstract

Boulad, F.; Riviere, I.; Wang, X.; Bartido, S.; Prockop, S. E.; Barone, R.; Moi, P.; Maggio, A.; Sadelain, M.
Blood (2013)

Fulltext@MSK | Save